Incogen
Private Company
Funding information not available
Overview
INCOGEN is a long-established, private bioinformatics and AI/ML software company providing analytical platforms and research support services to the biomedical research community. Its core business is developing and licensing software tools like VIBE™ and GenePort® for data integration, visualization, and analysis, with a focus on complex disease research such as cancer. The company operates a hybrid model of platform licensing and scientific services, catering primarily to corporate, academic, and government research laboratories worldwide.
Technology Platform
A suite of integrated bioinformatics software platforms including VIBE™ (visual workflow environment), GenePort® (data mining/management portal), and LabrePort™ (web-based LIMS). The platform focuses on data integration, visualization, and analysis of heterogeneous multi-omics data for complex disease research.
Opportunities
Risk Factors
Competitive Landscape
INCOGEN competes in the broad bioinformatics software market against large life science tools companies (e.g., Thermo Fisher, Qiagen), enterprise software giants (e.g., SAP, Dassault Systèmes), and a plethora of specialized startups offering AI/ML and data analysis platforms. Its differentiation lies in its long history, integrated toolset, and specific expertise in visualization and workflow management.